Latest Breaking News On - Markus manns - Page 2 : comparemela.com

Health: Blockbuster obesity drug demand drives Novo Nordisk profit boost

Health: Blockbuster obesity drug demand drives Novo Nordisk profit boost
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLars fruergaard jorgensenKarsten munk knudsenEli lillyMarkus mannsJyske bankNovo holdingsUnion investmentUs federal trade commissionNovo nordiskFruergaard jorgensenChief financial officer karsten munk knudsenTrade commission

Novo Nordisk raises outlook fuelled by obesity drug demand By Reuters

Novo Nordisk raises outlook fuelled by obesity drug demand By Reuters
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomEli lillyLars fruergaard jorgensenKarsten munk knudsenMaggie fickMarkus mannsUnion investmentNovo nordiskFruergaard jorgensenChief financial officer karsten munk knudsen

Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drug

Novo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly

United statesUnited kingdomEli lillyKarsten munk knudsenMarkus mannsLars fruergaard jorgensenNovo holdingsUnion investmentNovo nordiskJyske bankUs federal trade commissionLog increate freeFruergaard jorgensenChief financial officer karsten munk knudsenTrade commission

Bayer investors weigh need for cash call amid stifling debt

Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room,.

Markus mannsJulius baerJosephine masonFabian wennerBill andersonMartin schneeLudwig burgerChristina fincherWerner baumannPatricia weissUnion investment

Analysis-Bayer investors weigh need for cash call amid stifling debt

Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room, analysts said. But new CEO Bill Anderson may struggle to win over investors, who have seen the company's value sink by two thirds since its $63 billion acquisition of Monsanto in 2018, which saddled it with costly litigation and debt. The debate over a possible share issue comes as Anderson, who was hired last June to revive the company's fortunes, prepares to deliver a strategic investor update in London on Tuesday.

Christina fincherPatricia weissWerner baumannMartin schneeBill andersonLudwig burgerJosephine masonFabian wennerMarkus mannsJulius baerUnion investmentCapital increaseMartin schneeOstly litigation